YCBD
YCBD
AMEX · Pharmaceuticals

Cbdmd Inc

$0.78
+0.02 (+2.05%)
As of Mar 25, 5:40 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,458.0% upside
Low Target $15.39
Average Target $27.92
High Target $30.56
Current Price $0.78
Current
$0.78
Target
$27.92
$15.39 $27.92 avg $30.56
Scenario Analysis
Bear Case
$15.39
1,861.3%
Low target
Base Case
$27.92
+3,458.0%
Avg target
Bull Case
$30.56
+3,794.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.36
-76.6% from high
52-Week Low
$0.47
+66.9% from low
Target vs 52W High
$27.92
+731.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%